- Suppliers
ADM 
Antares 
Armor Pharma 
Asahi KASEI 
Ashland 
BASF 
Beneo 
Captisol 
Clariant 
Croda 
DFE Pharma 
Dow 
Excipio Chemicals 
Fuji Chemical 
Gattefossé 
Gangwal 
IOI Oleo 
Ingredient Pharm 
JRS Pharma 
Kerry 
KLK Oleo 
Lipoid 
Lubrizol Life Science Health 
MAGNESIA 
MEGGLE 
Nagase Viita 
Nordic Bioproducts 
pharm-a-spheres 
PMC Isochem 
PQ 
Seppic 
ShinEtsu 
Sigachi 
SPI Pharma 
Südzucker 
Vikram Thermo 
Zerion Pharma 
All4Nutra
- Suppliers
ADM Antares Armor Pharma Asahi KASEI Ashland BASF Beneo Captisol Clariant Croda DFE Pharma Dow Excipio Chemicals Fuji Chemical Gattefossé Gangwal IOI Oleo Ingredient Pharm JRS Pharma Kerry KLK Oleo Lipoid Lubrizol Life Science Health MAGNESIA MEGGLE Nagase Viita Nordic Bioproducts pharm-a-spheres PMC Isochem PQ Seppic ShinEtsu Sigachi SPI Pharma Südzucker Vikram Thermo Zerion Pharma - All4Nutra
Overview Live Pharmaceutical Webinars and Webinar Recordings
Webinare-Startseite
See Dr. TaBlitz Live, Episode 3
See Dr. TaBlitz Live, Episode 3
Building directly on Episode 2, we dive into the feeder system itself — the heart of consistent die filling. Learn exactly what a feeder is and the essential elements that determine whether powder gets into the feeder and then reliably into the die.
We cover the key components (hopper, feeder frame, paddles), plus critical operating factors including head pressure consistency, valve control, feeder speed, paddle design, and feeder frame ride height. You’ll leave with actionable insights to improve powder delivery and reduce weight variation.
This episode also sets the stage for understanding why powder properties matter so much in the episodes ahead.
Live demonstration and Q&A included.
For more information & watch it here:
When lipids go solid: process strategies to enhance bioavailability in oral dosage forms
When lipids go solid: process strategies to enhance bioavailability in oral dosage forms
MORE INFORMATION & registration
Lipid excipients have a proven history of enhancing bioavailability of drugs through the improvement of the solubility, the permeability, and the absorption. Being often liquid at room temperature, they are mainly formulated in liquid forms, like in soft or in hard capsules. That said, oral solid dosages forms such as tablets, could benefit from the advantages of lipid excipients.
Gattefossé will highlight different processes to incorporate lipid excipients in oral tablets or powders, during a webinar which will include the following topics:
- Benefits of lipid excipients for bioenhancement,
- Market references,
- Case studies highlighting formulation strategies and associated manufacturing.
Date & Time & Timezone:
- Tue, Jun 30, 2026, 9:30 AM – 10:30 AM CEST Amsterdam, Berlin, Rome, Stockholm, Vienna
or - Tue, Jul 7, 2026, 11:30 AM – 12:30 PM CEST Amsterdam, Berlin, Rome, Stockholm, Vienna
For more information & registration here:
Recorded Webinars:
Smarter Stabilization for Lipid Nanoparticles: Formulating Biopharmaceuticals with Sucrose
Optimizing Pharmaceutical Formulations: Strategies for Improving Stability and Minimizing Impurities
Rethinking the development of controlled release formulations and manufacturing processes
Rational Selection of Cyclodextrins for the Solubilization of Poorly Soluble Oral Drugs
Solving capping challenges using mannitol as an excipient model
Development of directly compressible formulations of Sitagliptin hydrochloride and Sitagliptin phosphate.
Antioxidants, a safe and viable Inhibition Strategy for Nitrosamine Formation In Drug Products
Rational Selection and Application of Ready-to-Use Formulations for Self-Emulsifying Drug Delivery Systems
Glatt: Pellets from fluid bed processes – a smart concept for high(er) potent drug processing
From powder to DC oral solid dosage form – using galenIQ™, the sweet-tasting filler binder.
Solving one of the biggest limitations of modern clinical trials: Patient Recruitment
Multiparticulates Part 8: Scale up considerations on the Wurster (bottomspray) fluidized bed process
Multiparticulates – modern oral drug products for our society; Part 6: DoE case studies in QbD development
Don’t Feed the Trolls – Crazy Powders and Electrostatic Charge in Continuous Manufacturing
Multiparticulates 5 – Product and process development applying QbD and DoE concepts to define DS
Addressing Raw Material Handling Challenges by Dry Granulation
Rx & OTC Product Line Extensions with Oral Lipid-Based Delivery Platforms
Merck: 3D Printing – shaping the future of formulation development
Multiparticulates 4b – Glatt Fluidbed Wurster Drug Layering and Coating – the Process
Multiparticulates Part IVa: Functional Coating Applications – The Basics
Multiparticulates for paediatric oral drug delivery
Neutral And Functional Starter Pellets
The Easy Way Of Tableting: Excipient Premixes For Direct Compression
Multiparticulates From Matric Core Pellets – Glatt CPS® Technology
Market Trends & Clean Label Solutions for Solid Oral Dosage Forms
Multiparticulates As Modern Oral Drug Products
Multiparticulates Part III: Multiparticulates From Matrix Core Pellets – Glatt MicroPx And ProCell Technology
Innovative Technologies For Amorphous Solid Dispersions
A beginners guide to SELF’ies for solubility and oral bioavailability enhancement
